Could a simple gel soothe heartburn without drugs? new trial aims to find out
NCT ID NCT07624383
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new medical device that forms a protective barrier in the esophagus to reduce heartburn and other GERD symptoms. Fifty adults with non-erosive GERD will take the device or a placebo four times daily for two weeks, then switch. The goal is to see if it relieves symptoms and improves quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
alginate-based esophageal barrier medical device
What this could lead to
If it works, this could offer a new, non-drug option for people with GERD to manage their symptoms.
What could go wrong
This is a small, early-stage trial with only 50 participants. The device may not work better than placebo, and results may not apply to everyone with GERD.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERD (GASTROESOPHAGEAL REFLUX DISEASE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical Network
Warsaw, Masovian Voivodeship, 04-501, Poland
Contact Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••